These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15283323)

  • 41. Finding a rational approach to ESA therapy--for payers and patients.
    Messana A
    Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
    [No Abstract]   [Full Text] [Related]  

  • 42. A 35-year-old woman with renal failure and pulmonary hemorrhage.
    Tojo T; Okano Y; Hosoda Y; Akizuki M; Onaka A; Suzuki H; Kanazawa M; Goto N; Handa M; Kobayashi Y
    Keio J Med; 1989 Sep; 38(3):325-47. PubMed ID: 2585945
    [No Abstract]   [Full Text] [Related]  

  • 43. The CARI guidelines. Renal transplantation.
    Toussaint N;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S37-43. PubMed ID: 18713122
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
    Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
    Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Coping with pathological changes in heart and lung in collagen diseases--pulmonary alveolar hemorrhage].
    Yamakido M; Isobe T
    Nihon Naika Gakkai Zasshi; 1996 Nov; 85(11):1845-9. PubMed ID: 9019504
    [No Abstract]   [Full Text] [Related]  

  • 46. [Favourable effects of the treatment of renal anemia in early stage chronic renal failure].
    Kes P
    Lijec Vjesn; 2002; 124(3-4):108-9. PubMed ID: 18956830
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of the therapeutic effects of epoetin zeta to epoetin alfa in the maintenance phase of renal anaemia treatment.
    Wizemann V; Rutkowski B; Baldamus C; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 Mar; 24(3):625-37. PubMed ID: 18208642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Respiratory failure secondary to organizing pneumonia in a patient with membranoproliferative glomerulonephritis and lung haemorrhage.
    Sánchez R; Gil J; Barroso E; Rivera F; Aranda I; Romero S
    Respiration; 2007; 74(5):592-4. PubMed ID: 16195657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of an immunochemical test for determination of ESF in some anemic states].
    Fiorio P; Vagge R; Lamperi S
    Boll Soc Ital Biol Sper; 1976 Dec; 52(23):1972-7. PubMed ID: 1027469
    [No Abstract]   [Full Text] [Related]  

  • 50. The role ANCA and anti-GBM antibodies in pulmonary-renal syndrome due to Wegener's granulomatosis.
    Zycinska K; Wardyn KA; Zielonka TM; Otto M
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):839-46. PubMed ID: 18204198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ESA therapy for anemia management: a call for civil discourse.
    McAllister CJ
    Nephrol News Issues; 2007 Jun; 21(7):49-50. PubMed ID: 17623986
    [No Abstract]   [Full Text] [Related]  

  • 52. Association of ANCA-positive vasculitis with thyroid disease.
    Rothe HM; Siegmund J; Müller H; Wopperer J
    Nephrol Dial Transplant; 2008 Jun; 23(6):2107; author reply 2107-8. PubMed ID: 18323519
    [No Abstract]   [Full Text] [Related]  

  • 53. Systemic antineutrophil cytoplasmic antibody vasculitis in a patient with chronic lymphocytic leukemia: quite a rare diagnosis.
    Pamuk GE; Uyanik MS; Demir M; Tekgündüz E; Turgut B; Soy M
    Leuk Res; 2007 Aug; 31(8):1149-51. PubMed ID: 17010431
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ANCA-associated renal vasculitis at the end of the twentieth century--a disease of older patients.
    Harper L; Savage CO
    Rheumatology (Oxford); 2005 Apr; 44(4):495-501. PubMed ID: 15613403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Anemia in the dialyzed patient].
    Deray G
    Soins; 2003 Oct; (679 Suppl):17. PubMed ID: 14621469
    [No Abstract]   [Full Text] [Related]  

  • 56. Iron supplementation in renal anemia.
    Fishbane S
    Semin Nephrol; 2006 Jul; 26(4):319-24. PubMed ID: 16949471
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ACE inhibitors or angiotensin II receptor blockers in dialysed patients and erythropoietin resistance.
    Saudan P; Halabi G; Perneger T; Wasserfallen JB; Wauters JP; Martin PY;
    J Nephrol; 2006; 19(1):91-6. PubMed ID: 16523432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study.
    de Francisco AL; Sulowicz W; Klinger M; Niemczyk S; Vargemezis V; Metivier F; Dougherty FC; Oguey D;
    Int J Clin Pract; 2006 Dec; 60(12):1687-96. PubMed ID: 17109676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Target hemoglobin level for EPO therapy in CKD.
    Parfrey PS
    Am J Kidney Dis; 2006 Jan; 47(1):171-3. PubMed ID: 16377399
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical characteristics of propylthiouracil (PTU) induced antineutrophil cytoplasmic antibodies positive cases; analysis of a case of PTU-induced ANCA positive patients with hyperthyroidism].
    Li MT; Zeng XJ; Fang WG; Li H; Li XM; Feng K; Li YZ; Zeng XF; Zhang FC; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2082-5. PubMed ID: 15730621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.